RecruitingNot ApplicableNCT02920554

The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer

The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer Operation: Prospective Randomized Controlled Trial


Sponsor

Saint Vincent's Hospital, Korea

Enrollment

88 participants

Start Date

Jul 1, 2014

Study Type

INTERVENTIONAL

Conditions

Summary

The extent of hepatic resection for gallbladder cancer can be done from a wedge resection to 4b/5 bisegmentectomy. This study aims to compare the recurrence rates and survival rates between wedge resection group and bisegmentectomy group. Patients with T2 or T3 gallbladder cancer on preoperative CT exam or patients who were pathologically diagnosed as T2 or T3 gallbladder cancer after initial simple cholecystectomy were enrolled. All patients are randomly assigned to wedge resection or bisegmentectomy group. Number of patients in each group is 44. Primary endpoint is recurrence-free-survival rates and overall survival rates.


Eligibility

Min Age: 19 YearsMax Age: 80 Years

Inclusion Criteria2

  • Patients with T2 or T3 gallbladder cancer on preoperative CT exam
  • Patients who are pathologically diagnosed as T2 or T3 gallbladder cancer after initial simple cholecystectomy

Exclusion Criteria4

  • Peritoneal seeding or distant metastasis
  • Impossible to resect the cancer radically
  • Pathologically diagnosed to other malignancy such as adenosquamous carcinoma, sarcoma, etc.
  • R1 or R2 resection were pathologically diagnosed.

Interventions

PROCEDUREwedge resection

The extent of hepatic resection is wedge resection of liver including gallbladder fossa

PROCEDUREbisegmentectomy

The extent of hepatic resection is 4b/5 bisegmentectomy of liver


Locations(1)

the Catholic University of Korea St. Vincent's Hospital

Suwon, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02920554


Related Trials